Hexaspray aerosol for topical application 2.5% 30 g №1

Name:
Hexaspray aer.d/local approx. 2.5% in flask 30g in pack №1
Description:
Homogeneous suspension of white color with a yellowish tint with a characteristic smell of anise. The main active ingredient Biclotymol Release form Aerosol Dosage 2.5% Special instructions Keep the bottle upright during use. Shake the bottle before use. Therapy does not justify long-term treatment, especially since prolonged use of the drug for more than 5 days can disrupt the normal microflora of the mouth and throat, with the risk of bacterial or fungal spread. If symptoms persist within 5 days and/or are accompanied by fever, treatment should be reconsidered. Simultaneous or sequential use of antiseptics with biclotymol should be avoided, taking into account possible interactions (antagonism, inactivation). Soy lecithin can cause allergic reactions. The drug contains a small amount of alcohol, less than 100 mg per dose. Due to the content of methyl parahydroxybenzoate (E218), it can cause allergic reactions (including delayed ones). Pharmacodynamics Antimicrobial topical drug with antimicrobial activity. Biclotymol belongs to the biphenol class. Biclotymol has activity against Gram-positive microorganisms under the following conditions: 15 minutes from contact to maximum concentration (900/0). Pharmacokinetics Not known. Preclinical safety data Not known. Indications for use The drug is indicated for the local treatment of infectious and inflammatory diseases of the oral mucosa and pharynx, which are not accompanied by fever. In the event of general signs of a bacterial infection, antibiotics for systemic use should be considered. Dosage and administration Adults and children over 6 years of age: 2 injections 3 times a day, regardless of food intake. Treatment should be limited to 5 days. Use during pregnancy and lactation There are no reliable data on the teratogenic effect in animals. Clinically, no teratogenic effect and the effect of fetotoxicity in women has not yet been manifested. However, monitoring of pregnant women treated with biclotymol is not sufficient to rule out any risk. Therefore, as a precaution, it is preferable not to use biclotymol. Interaction with other drugs Avoid the simultaneous use of other local agents. Contraindications Children’s age up to 6 years. Hypersensitivity to the components of the drug. Composition Per bottle Active ingredients: Biclotymol 0.75 g Excipients: Benzyl alcohol 0.50 g Disodium edetate 0.0025 g Methyl parahydroxybenzoate (E218) 0.025 g Anise star seed oil 0.03 g Ammonium glycyrrhizinate 0.02 g Sodium saccharinate 0.05 g Avicel RC 591 (microcrystalline cellulose and carmellose sodium) 0.30 g Soy lecithin 0.90 g Glycerol 1.06 g Ethanol 96% 1.06 g Water 30.00 g reactions, which are presented in accordance with the MedRA classification by body systems and by frequency of occurrence and are conditionally defined as follows: Very common (? 1/10) Frequent (? 1/100, <1/10) Rare (? 1/10,000 <1/1000) Very rare (<1/10,000) Not known (cannot be estimated from the available data) Immune system side effects Very rare: Lip edema, urticaria, angioedema. Not Known: Hypersensitivity to biclotymol or other ingredients such as soy lecithin. Skin and subcutaneous tissue disorders Very rare: rash, erythema. Collecting reports of suspected adverse reactions after drug registration is important. This allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report suspected adverse reactions through the national reporting system. Storage conditions At a temperature not exceeding 25 ° C, out of the reach of children. Buy Hexaspray topical aerosol 2.5% 30 g №1